TickerFacts.

Nephros Inc (NEPH): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.44M
As of 2025-12-31
$3.80M
As of 2026-06-30
+17.5%
3-year compound annual growth
+3.2%
5-year compound annual growth
+10.2%
10-year compound annual growth
$9.05M2011-12-31: $2.57M2012-12-31: $4.12M2013-12-31: $6.61M2014-12-31: $9.05M2015-12-31: $1.31M2016-12-31: $2.01M2017-12-31: $3.03M2018-12-31: $3.76M2019-12-31: $3.94M2020-12-31: $2.94M2021-12-31: $2.90M2022-12-31: $2.12M2023-12-31: $3.50M2024-12-31: $2.62M2025-12-31: $3.44M$3.44M
2011-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$3.44M+31.0%2026-03-12, Balance as of period end
2024-12-31$2.62M-25.1%2026-03-12, Balance as of period end
2023-12-31$3.50M+65.4%2025-03-24, Balance as of period end
2022-12-31$2.12M-27.0%2024-03-15, Balance as of period end
2021-12-31$2.90M-1.2%2023-03-23, Balance as of period end
2020-12-31$2.94M-25.5%2022-03-03, Balance as of period end
2019-12-31$3.94M+4.8%2021-03-01, Balance as of period end
2018-12-31$3.76M+24.0%2020-02-27, Balance as of period end
2017-12-31$3.03M+50.8%2019-03-12, Balance as of period end
2016-12-31$2.01M+54.0%2018-02-26, Balance as of period end
2015-12-31$1.31M-85.6%2017-03-20, Balance as of period end
2014-12-31$9.05M+37.0%2016-03-30, Balance as of period end
2013-12-31$6.61Mn/c2015-04-15, Balance as of period end
2012-12-31$4.12M+60.2%2014-03-28, Balance as of period end
2011-12-31$2.57Mn/a2013-03-04, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Nephros Inc (NEPH)2025-12-31$3.44M+31.0%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$10.87M+17.1%
Spectral AI, Inc. (MDAI)2025-12-31$27.13M+40.2%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$26.70M+264.3%
Profound Medical Corp. (PROF)2025-12-31$11.04M+12.5%
Biotricity Inc. (BTCY)2026-03-31$39.41M+10.5%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$38.48M+0.7%
Allurion Technologies, Inc. (ALUR)2025-12-31$92.96M-16.1%
Sensus Healthcare, Inc. (SRTS)2025-12-31$4.94M-22.0%

Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗